Abbott Laboratories (ABT) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for ABT. 13F holdings as of 2026-06-30.

In 13F filings for the quarter ended June 30, 2026, 2,945 institutions reported holding ABT, with 1.4 billion shares worth $124.1 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
Vanguard181,546,637$16.5BINCREASED
BlackRock152,563,476$13.8BINCREASED
State Street80,926,234$7.3BINCREASED
Capital Group71,667,305$6.5BDECREASED
Charles Schwab Investment Management59,674,507$5.4BINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
John G Stratton (Director)AWARD397$39K2026-09-30
Patricia Paola Gonzalez (Director)AWARD333$33K2026-09-30
Kevin T Conroy (Director)AWARD318$31K2026-09-30
Nita Ahuja (Director)AWARD318$31K2026-09-30
Michael F Roman (Director)AWARD381$38K2026-09-30

Recent Congressional Trades

MemberTypeAmountDate
Pete Sessions (Republican)SALE$50,001 - $100,0002026-10-02
Gilbert Cisneros (Democrat)PURCHASE$1,001 - $15,0002026-09-18
Ro Khanna (Democrat)PURCHASE$1,001 - $15,0002026-09-04

Full institutional holdings, insider history, and congressional trades for Abbott Laboratories on SentiSense.